Que Future Mas Bello

“The future is bright,” to quote  Spanish crooner Pablo Alboran. And so it is, especially for members of the AAWC. In the next series of weekly Presidential addresses, I want to share how the accomplishments of 2018 have set the platform for a successful 2019 and beyond.
 
     Strategic Partnerships: Among the AAWC’s strongest initiatives is the Wound-Care Experts FDA-Clinical Endpoints Project (WEF-CEP). This collaborative project with the Wound Healing Society focuses on clinically relevant endpoints for wound-healing clinical trials. The result is advanced wound care products will have a smoother FDA approval pathway providing cutting edge solutions for our patients.
 
     Influential Leadership: A recently accepted article to be published in Wound Repair and Regeneration entitled “Evidence Supporting Wound Care Endpoints Relevant to Clinical Practice and Patients' Lives. Part 2. Literature Survey” was written by members of the WEF-CEP Committee. The compelling findings enabled Peggy Dotson, Marissa Carter, Vickie Driver and Gary Gibbons to appear before the FDA to discuss the details.
    
    Patient Participation: The WEF-CEP Committee reached out to those beneficiaries of our care to ask patients for their perspective on wound care products. The findings from over 400 patients are currently under review and will be published once available.  As a next step, the committee will recommend up to four scientifically achievable, clinically relevant, & patient-centered wound endpoints to serve as primary wound care outcome to the FDA.

    Your AAWC is engaged, influencing policy, and is being heard by the FDA to advocate for patients and clinicians. These are meritable achievements and a credit to your leadership and membership engagement. These accomplishments are the basis of the AAWC’s commitment to speak as one voice for the wound community.

To learn more about the WEF-CEP Project you may access the November AAWC Journal Club Webinar presented by Drs. Lisa Gould and Vickie Driver on the subject.